Viewing Study NCT05945368


Ignite Creation Date: 2025-12-24 @ 5:48 PM
Ignite Modification Date: 2025-12-28 @ 12:12 AM
Study NCT ID: NCT05945368
Status: UNKNOWN
Last Update Posted: 2023-07-14
First Post: 2023-05-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BC
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module